Cellular Agriculture Australia’s Post

The U.S. is already benefitting from biomanufacturing, accounting for about $440 billion added to our bioeconomy as of 2019 and 1.65 million jobs created by the bioproduct industry as of 2017. Learn how BioMADE is continuing this work to bolster the U.S. bioeconomy:

Discussions with companies of the Industrial Bioeconomy as well as the Dialog platform to Industrial Bioeconomy of the BMWK On the 5th of September 2024, a continuation of the discussion with Industrial #Bioeconomy companies and the Industrial Bioeconomy Dialogue Platform took place at the Bundesministerium für Wirtschaft und Klimaschutz (BMWK). Together with Federal Minister for Economic Affairs Robert Habeck and Parliamentary State Secretary at the BMWK Michael Kellner, proposals, and solutions from the working groups on the topics of raw materials, scaling, regulation, financing, and market incentivization were discussed, as well as the next steps. Further elaboration of the topics is to take place at a symposium on October 7 and 8 at the BMWK in Berlin with the theme: “Research, develop, scale, transform - shaping the bioeconomy together for sustainability and competitiveness!”. The event is primarily aimed at industry representatives. Registration is possible at the following link biooekonomie.vdi-tz.de BIO Deutschland Managing Director Viola Bronsema, as a member of the dialog platform and head of WG 3 - Pilot Plants and Technology, was involved in the discussions with Federal Minister of Economics Robert Habeck and Parliamentary State Secretary at the BMWK Michael Kellner. The dialog platform was founded in 2018 under the previous government to develop measures for the Federal Ministry of Economics to implement the industrial bioeconomy.

Exciting news from the Department of Defense (DoD) as five companies are receiving a total of $9 million for the Distributed Bioindustrial Manufacturing Program (DBIMP) to expand the domestic supply of materials for U.S. supply chains through bioproduction infrastructure.     These awards are part of the White House's initiative to advance biotechnology and biomanufacturing innovation, ultimately strengthening our national and economic security. The companies receiving the awards include ARCTOS Technology Solutions, CleanJoule, Lygos, Synonym, and Visolis. These advancements represent a significant step toward achieving a robust American bioeconomy and a vibrant industrial base.    To read the full press release visit: https://lnkd.in/eX8ZYteg

We are honored to announce that Synonym has been awarded $1.89M by the United States Department of Defense for the Distributed Bioindustrial Manufacturing Program (DBIMP). This program aims to expand the domestic supply of ingredients and materials for US supply chains by building biomanufacturing infrastructure. This award, part of the White House's Executive Order 14081, underscores our commitment to bolstering America's bioeconomic strengths while advancing defense capabilities. With this funding, Synonym will develop comprehensive business and technical plans to refurbish or build a new precision fermentation facility for the domestic supply of products critical to US supply chains. Facility locations in Illinois, Indiana, and Tennessee are being considered. Successful completion of this project could lead to a follow-on award of up to $100M to build the facility. Please keep an eye out for more updates on this exciting project. The full Department of Defense’s press release is linked in the post below. #bioeconomy #biomanufacturing #dod #infrastructure #fermentation #precisionfermentation #supplychain

🔬 Dive into the cutting-edge world of Microbial and Enzyme Engineering for Bioproduction! 🌱 Unlock valuable insights with this mind map. Stay ahead of the curve and revolutionize your approach to innovation. Ready to elevate your game? Check it out now!

We’re excited to share that Cauldron Ferm has been awarded $1.76 million from the United States Department of Defense to plan a U.S.-based commercial-scale facility. As Heidi Shyu, Under Secretary of Defense for Research and Engineering, highlights in the announcement: "The next industrial revolution will be a biomanufacturing revolution.” We are honoured to be part of this pioneering DoD Distributed Bioindustrial Manufacturing Program (DBIMP) to help transition U.S. bioindustrial manufacturing from the laboratory to a network of large-scale production facilities. The Cauldron U.S. facility will use hyper-fermentation to produce precision-fermented products ranging from food proteins to fuels and chemicals at a lower cost than traditional production methods. With this announcement of our first U.S. facility – expanding Cauldron’s footprint from our current demo operations and first planned industrial site in Australia – there’s incredible momentum behind our mission to solve the gap in commercially viable biomanufacturing capacity. Read more about the announcement here: https://bit.ly/4fZuv3Q We’re proud to be part of this global movement fueling a thriving global bioeconomy 🌐 Congratulations to the other awardees! Amyris, Checkerspot, DSM, The EVERY Company, The Fynder Group, Liberation Labs, Perfect Day, Solugen. #biomanufacturing #DBIMP #bioeconomy #precisionfermentation

Congratulations to our portfolio company ZymoChem on winning over $1.5 million from the United States Department of Defense to build a state-of-the-art bioproduction facility! 𝐀𝐧𝐧𝐨𝐮𝐧𝐜𝐞𝐦𝐞𝐧𝐭 𝐚𝐭 𝐚 𝐠𝐥𝐚𝐧𝐜𝐞 🧬 ZymoChem uses engineered microbes to manufacture biobased monomers using engineered microbes, which are essential for fabricating military fabrics, tactical gear, aerospace materials, and more. 🏆 Seven biotech companies were awarded grant funding under the Distributed Bioindustrial Manufacturing Program (DBIMP). The other six winners include Battelle, Biosphere, Geno, iMicrobes, Modular Genetics, Inc., and The Better Meat Co. 🏭 DBIMP-awarded companies are eligible to receive up to $100 million to access bioindustrial manufacturing facilities in the U.S., a huge opportunity for infrastructure development in the biotech industry. 𝐑𝐞𝐚𝐝 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐫𝐞𝐥𝐞𝐚𝐬𝐞: https://lnkd.in/d38qVVPS

How we enabled Arxada to differentiate itself from its competitors. We recently developed and launched a purpose statement for Arxada, the Switzerland-based global chemicals company: “Better science to solve the world’s toughest preservation challenges.” It differentiates it from its competitors by pushing it to win through better science. “Better science" pushes it to be technically better than its competitors. It pushes it to always be looking for new scientific advances. And it pushes it to harness its investment in biotech to lead the chemical sector on reducing environmental impact. Finally, by calling out the “world’s toughest preservation challenges” it identified a wider array of preservation opportunities where its expertise can have impact, and where solving those tough challenges will allow it to charge higher margins. The purpose statement has stretch and teeth, enabling it to unlock renewed energy, impact and opportunities to grow. Check out more great examples of purpose-driven businesses in our book "Every Team Actually Doing Business Better." Get your copy here: https://lnkd.in/eD7kw7XA

“By addressing key regulatory obstacles, Europe can unleash innovation in biotechnology, with the power to positively impact lives and improve sustainability.” Last month, our SVP of Biotechnology Adam Burja gave a keynote speech at a EuropaBio - the European Association for Bioindustries event about the future of biotech in Europe. Key insights included: 🔬 Biotech can help meet two key societal challenges we all face – sustainability and health. 🧬 Existing EU legislation is not equipped to support address the latest scientific advancements in Biotech and Biomanufacturing, particularly in engineering biology and precision fermentation. 📖 Europe needs a future-ready proof, product-centric regulatory framework that encourages innovation. #shapethefuture

Our Executive Director Joel Tickner took part as a panelist in the 'Reflections on #SSbD implementation' session of the Accelerating the Industrial Transition with Safe-and-Sustainable-by-Design webinar organised by IRISS – International SSbD network. In this session that was moderated by Lya G. Soeteman-Hernandez of RIVM National Institute for Public Health and the Environment, Joel was joined by other panelists Dmitri Petrovykh of INL - International Iberian Nanotechnology Laboratory, Philippe JACQUES of EMIRI and Ann Dierckx of Essencia. It was also great to hear the presentation by Dr. Wibke Lölsberg of our members BASF. Our key learnings from Joel's input were as follows: ✅ The Safe and Sustainable by Design concept has been around since the early 90s, however the right timing and right space to action it is now. We need to move it from flavour of the day to an actionable framework that will have profound practicable impact. It needs to be implementable not just for industry giants but for SMEs alike. ✅ The incentivisation of SSbD is key for its adoption, especially due to its non-mandatory nature). ✅ Another important factor to consider is #collaboration; not just between the industry, academia, policymakers, NGOs and other organisations but also internal collaboration within the companies along the value chains. Alignment between R&D/Sustainability teams vs Business teams on design and other decisions on chemicals is crucial. Want to know more about our organisation and how we are working to #change #chemistry?: https://lnkd.in/dZK7bRR9 #changemakers #europeanpolicy #chemicals #sustainablechemistry